Development of High Dose Oseltamivir Phosphate Dry Powder for Inhalation Therapy in Viral Pneumonia
Oseltamivir phosphate (OP) is an antiviral drug available only as oral therapy for the treatment of influenza and as a potential treatment option when in combination with other medication in the fight against the corona virus disease (COVID-19) pneumonia. In this study, OP was formulated as a dry po...
Main Authors: | Shahir Aziz, Regina Scherlieβ, Hartwig Steckel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/12/1154 |
Similar Items
-
The qualitative determination of oseltamivir phosphate in Tamiflu® capsule by cyclic voltammetry
by: Avramov-Ivić Milka L., et al.
Published: (2011-01-01) -
Trehalose addition to a Tris-fructose egg yolk extender on quality of ram sperm preserved at 0 °C
by: Jianqing Zhao, et al.
Published: (2020-11-01) -
Neurotoxic effect in lactating mice pups received oseltamivir phosphate (tamiflu) through milk from dosed nursing mothers during lactation period
by: Areej B. Abass
Published: (2012-06-01) -
Studies on the spray dried lactose as carrier for dry powder inhalation
by: Linna Wu, et al.
Published: (2014-12-01) -
Oseltamivir phosphate for suspension is bioequivalent to TAMIFLU in healthy volunteers: a randomized, open-label clinical study
by: Ying Wang, et al.
Published: (2023-02-01)